Summary
- Current Price
- IPA price is unknown, with unknown change on
- Current Price All-Time High
- IPA price vs all-time high is unknown
- Market Cap
- IPA market cap is unknown, with unknown 1-year change
- PE Ratio
- IPA PE ratio is unknown
- Revenue
- IPA current annual revenue is $17.60M, down -3.09% year-over-year
- Next Earnings
- As of today, the next earnings release for IPA has not been scheduled
Profile
| Metric | Value |
|---|---|
| Full Name | ImmunoPrecise Antibodies Ltd. |
| Ticker | NASDAQ: IPA |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | ipatherapeutics.com |
| Employees | 81 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| - | ||
| Price, 1D Change | - | |
| - | ||
| - | ||
| - | ||
| N/A | - | |
| $18M | ||
| Revenue, 1Y Change | -3.09% | |
| -$0.65 | ||
| EPS, 1Y Change | +13.56% |
Chart
Add series to chart(max: 6)
Series
SUGGESTED SERIES
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | N/A | |
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | 1:5 | |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$0.65 | ||
| EPS Estimate | N/A | -$0.11 |
| EPS Est. Change | N/A | +83.38% |
| $17.60M | ||
| Revenue Estimate | N/A | $28.83M |
| Revenue Est. Change | N/A | +63.85% |
| - | ||
| Price Target | - | - |
| Price Tgt. Change | - | - |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$0.34 | -$0.76 | -122.18% | |
| - | -$0.65 | - | |
| -$0.11 | N/A | +83.38% | |
| $0.04 | N/A | +106.58% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $17.78M | $18.16M | +2.12% | |
| $25.43M | $17.60M | -30.81% | |
| $28.83M | N/A | +63.85% | |
| $38.10M | N/A | +116.52% |
🔒 Log In To Unlock Full Data
Performance
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| -3.09% | ||
| +14.03% | ||
| +13.56% | ||
| +3.59% |
🔒 Log In To Unlock Full Data
Technical Indicators
| Metric | Date | Value |
|---|---|---|
| - | ||
| N/A | - | |
| SMA 200 vs Price | N/A | - |
| N/A | - | |
| SMA 50 vs Price | N/A | - |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - | |
| N/A | - |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $17.60M | ||
| -$0.65 | ||
| $8.32M | ||
| 47.31% | ||
| -$8.74M | ||
| -50.47% | ||
| -$21.70M | ||
| -123.30% | ||
| -$20.68M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.00 | ||
| 2.08 | ||
| 1.85 | ||
| - | ||
| 5 | ||
| - |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| - | ||
| - | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $17.08M | ||
| $7.71M | ||
| $32.17M | ||
| $13.56M | ||
| $15.07M | ||
| $6.52M | ||
| $9.70M | ||
| $1.34M | ||
| $3.82M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $26.31M | ||
| $18.45M | ||
| $9.27M | ||
| $13.64M | ||
| $3.67M | ||
| $0.00 | ||
| -$2.89M |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$4.59M | ||
| -$573.40K | ||
| $10.69M | ||
| $573.40K | ||
| -$5.17M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| HC Wainwright & Co. | → | |
| Benchmark | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Benchmark | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Benchmark | → |
Analyst sentiment
Institutional ownership
Screeners with IPA
FAQ
What is the ticker symbol for ImmunoPrecise Antibodies Ltd.?
The ticker symbol for ImmunoPrecise Antibodies Ltd. is NASDAQ:IPA
Does ImmunoPrecise Antibodies Ltd. pay dividends?
No, ImmunoPrecise Antibodies Ltd. does not pay dividends
What sector is ImmunoPrecise Antibodies Ltd. in?
ImmunoPrecise Antibodies Ltd. is in the Healthcare sector
What industry is ImmunoPrecise Antibodies Ltd. in?
ImmunoPrecise Antibodies Ltd. is in the Biotechnology industry
What country is ImmunoPrecise Antibodies Ltd. based in?
ImmunoPrecise Antibodies Ltd. is headquartered in United States
When did ImmunoPrecise Antibodies Ltd. go public?
ImmunoPrecise Antibodies Ltd. initial public offering (IPO) was on January 7, 2002
Is ImmunoPrecise Antibodies Ltd. in the S&P 500?
No, ImmunoPrecise Antibodies Ltd. is not included in the S&P 500 index
Is ImmunoPrecise Antibodies Ltd. in the NASDAQ 100?
No, ImmunoPrecise Antibodies Ltd. is not included in the NASDAQ 100 index
Is ImmunoPrecise Antibodies Ltd. in the Dow Jones?
No, ImmunoPrecise Antibodies Ltd. is not included in the Dow Jones index
When was ImmunoPrecise Antibodies Ltd. last earnings report?
ImmunoPrecise Antibodies Ltd.'s most recent earnings report was on September 16, 2025
When does ImmunoPrecise Antibodies Ltd. report earnings?
The date for ImmunoPrecise Antibodies Ltd.'s next earnings report has not been announced yet
Data Sources & References
- IPA Official Website www.ipatherapeutics.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1715925/000095017025099392/0000950170-25-099392-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1715925/000095017025099392/0000950170-25-099392-index.htm
- IPA Profile on Yahoo Finance finance.yahoo.com/quote/IPA
- IPA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ipa